- Home
- ACHV vs NNBR Comparison
ACHV vs NNBR Comparison
Compare ACHV & NNBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACHV
- NNBR
- Stock Information
- Founded
- ACHV N/A
- NNBR 1980
- Country
- ACHV United States
- NNBR United States
- Employees
- ACHV N/A
- NNBR N/A
- Industry
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- NNBR Industrial Machinery/Components
- Sector
- ACHV Health Care
- NNBR Industrials
- Exchange
- ACHV Nasdaq
- NNBR Nasdaq
- Market Cap
- ACHV 131.3M
- NNBR 129.3M
- IPO Year
- ACHV N/A
- NNBR 1994
- Fundamental
- Price
- ACHV $2.93
- NNBR $2.51
- Analyst Decision
- ACHV Strong Buy
- NNBR
- Analyst Count
- ACHV 2
- NNBR 0
- Target Price
- ACHV $16.00
- NNBR N/A
- AVG Volume (30 Days)
- ACHV 1.5M
- NNBR 72.7K
- Earning Date
- ACHV 11-06-2025
- NNBR 10-29-2025
- Dividend Yield
- ACHV N/A
- NNBR N/A
- EPS Growth
- ACHV N/A
- NNBR N/A
- EPS
- ACHV N/A
- NNBR N/A
- Revenue
- ACHV N/A
- NNBR $433,709,000.00
- Revenue This Year
- ACHV N/A
- NNBR N/A
- Revenue Next Year
- ACHV N/A
- NNBR $4.88
- P/E Ratio
- ACHV N/A
- NNBR N/A
- Revenue Growth
- ACHV N/A
- NNBR N/A
- 52 Week Low
- ACHV $1.84
- NNBR $1.58
- 52 Week High
- ACHV $5.31
- NNBR $4.67
- Technical
- Relative Strength Index (RSI)
- ACHV 54.19
- NNBR 57.36
- Support Level
- ACHV $2.68
- NNBR $2.41
- Resistance Level
- ACHV $3.14
- NNBR $2.63
- Average True Range (ATR)
- ACHV 0.26
- NNBR 0.13
- MACD
- ACHV -0.00
- NNBR 0.00
- Stochastic Oscillator
- ACHV 40.43
- NNBR 69.23
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.
About NNBR NN Inc.
NN Inc is a diversified industrial company that combines engineering and production capabilities with in-depth materials science expertise to design and manufacture high-precision solutions and components. It operates in two business segments: mobile solutions and power solutions. The mobile solutions segment involves growth in the general industrial and automotive end markets. Its power solutions segment involves growth in the electrical and aerospace and defense end markets.